Skip to main content
  • Saved

made a Post

Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma

Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma

Source :

https://link.springer.com/article/10.1007/s00262-020-02716-3

Hyperprogression, characterized by a rapid acceleration in tumor growth, is a novel pattern of progression recently described in patients treated with immune checkpoint inhibitors. This study aims to assess the incidence of hyperprogression in patients with advanced melanoma treated with checkpoint inhibitors.